Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Not Yet Recruiting2

Clinical Trials (2)

Research Network

Active Sponsors

  • Assiut University1
  • Henan University of Traditional Chinese Medicine1

Top Investigators

  • The First Affiliated Hospital of Henan University of Traditional Chinese Medicine

Related Conditions

  • Chest Infection1
  • Multi Drug Resistant Infections1
  • Criticallyill Patients Admitted To The Icu For Acute Respitatory Failure Regardless The Aetilogy1

Activity Timeline